Swimmer plot of outcomes after SCB in all treated patients. Selected features evaluated as potential predictors of response to SCB (left). Clinical course of treated patients with outcomes (right). Response refers to hematologic response. Active disease refers to presence of nonmorphologic residual disease. Acute GVHD refers to the presence of any acute GVHD that onset before administering the SCB. AML, acute myeloid leukemia; MDS, myelodysplastic syndrome; NR, no response.